Use of Nicotinamide Mononucleotide as Non-Natural Cofactor
Catalysts,
Journal Year:
2025,
Volume and Issue:
15(1), P. 37 - 37
Published: Jan. 3, 2025
Nicotinamide
mononucleotide
(NMN)
has
emerged
as
a
promising
non-natural
cofactor
with
significant
potential
to
transform
biocatalysis,
synthetic
biology,
and
therapeutic
applications.
By
modulating
NAD⁺
metabolism,
NMN
offers
unique
advantages
in
enzymatic
reactions,
metabolic
engineering,
regenerative
medicine.
This
review
provides
comprehensive
analysis
of
NMN’s
biochemical
properties,
mechanisms
action,
diverse
Emphasis
is
placed
on
its
role
addressing
challenges
multi-enzyme
cascades,
biofuel
production,
the
synthesis
high-value
chemicals.
The
paper
also
highlights
critical
research
gaps,
including
need
for
scalable
methods,
improved
integration
into
systems,
toxicity
studies
use.
Emerging
technologies
such
AI-driven
enzyme
design
CRISPR-based
genome
engineering
are
discussed
transformative
tools
optimizing
NMN-dependent
pathways.
Furthermore,
synergistic
biology
innovations,
cell-free
systems
dynamic
regulatory
networks,
explored,
paving
way
precise
modular
biotechnological
solutions.
Looking
forward,
versatility
positions
it
pivotal
tool
advancing
sustainable
bioprocessing
precision
Addressing
current
limitations
through
interdisciplinary
approaches
will
enable
redefine
boundaries
innovation.
serves
roadmap
leveraging
across
scientific
industrial
domains.
Language: Английский
An overview of engineering microbial production of nicotinamide adenine mononucleotide
Baoxian Li,
No information about this author
Xiangfeng Meng,
No information about this author
Weifeng Liu
No information about this author
et al.
Journal of Biotechnology,
Journal Year:
2024,
Volume and Issue:
396, P. 80 - 88
Published: Nov. 2, 2024
Language: Английский
Systematic Engineering for High-level Production of β-nicotinamide mononucleotide from NAM and Ribose
Food Bioscience,
Journal Year:
2024,
Volume and Issue:
unknown, P. 105725 - 105725
Published: Dec. 1, 2024
Language: Английский
Harnessing lactic acid bacteria for nicotinamide mononucleotide biosynthesis: a review of strategies and future directions
Linghui Kong,
No information about this author
Xinyu Li,
No information about this author
Taiyu Liu
No information about this author
et al.
Frontiers in Microbiology,
Journal Year:
2024,
Volume and Issue:
15
Published: Dec. 13, 2024
Nicotinamide
mononucleotide
(NMN),
one
of
the
crucial
precursors
nicotinamide
adenine
dinucleotide,
has
garnered
considerable
interest
for
its
pharmacological
and
anti-aging
effects,
conferring
potential
health
economic
benefits
humans.
Lactic
acid
bacteria
(LAB)
are
most
important
probiotics,
which
is
commonly
used
in
dairy
industry.
Due
to
probiotic
properties,
it
presents
an
attractive
platform
food-grade
NMN
production.
LAB
have
also
been
extensively
utilized
enhance
functional
properties
pharmaceuticals
cosmetics,
making
them
promising
candidates
large-scale
up
synthesis
NMN.
This
review
provides
in-depth
analysis
various
metabolic
engineering
strategies,
including
enzyme
optimization,
pathway
rewiring,
fermentation
process
enhancements,
increase
yields
LAB.
It
explores
both
CRISPR/Cas9
traditional
methods
manipulate
key
biosynthetic
pathways.
In
particular,
this
study
discussed
future
research
directions,
emphasizing
application
synthetic
biology,
systems
AI-driven
optimization
further
invaluable
insights
into
developing
scalable
industrially
relevant
processes
production
meet
growing
market
demand.
Language: Английский